Reports - Next-Generation Sequencing Market
HealthcareNext-Generation Sequencing Market
Next-Generation Sequencing Market Size and Share Analysis for 2035 by Products & Services (NGS Consumables, Sequencing Services, Exome & Targeted Resequencing & Custom Panels, Whole-Genome Sequencing & De Novo Sequencing, RNA Sequencing, Other Sequencing Services, Presequencing Products & Services, Library Preparation & Target Enrichment, Quality Control, NGS Platforms, Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, Other Platforms, Bioinformatics, Services For NGS Platforms) by Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Other Technologies) by Application (Diagnostics, Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications, Drug Discovery, Agricultural & Animal Research, Other Applications) by End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Next-Generation Sequencing Market - Segment Analysis
1. Overview
2. Global Next-Generation Sequencing Market, 2021 - 2034 (USD Million)
3. Global Next-Generation Sequencing Market - by Products & Services
3.1. By NGS Consumables
3.2. By Sequencing Services
3.3. By Exome & Targeted Resequencing & Custom Panels
3.4. By Whole-Genome Sequencing & De Novo Sequencing
3.5. By RNA Sequencing
3.6. By Other Sequencing Services
3.7. By Presequencing Products & Services
3.8. By Library Preparation & Target Enrichment
3.9. By Quality Control
3.10. By NGS Platforms
3.11. By Illumina
3.12. By Thermo Fisher Scientific
3.13. By Oxford Nanopore Technologies
3.14. By Pacific Biosciences
3.15. By Other Platforms
3.16. By Bioinformatics
3.17. By Services For NGS Platforms
4. Global Next-Generation Sequencing Market - by Technology
4.1. By Sequencing By Synthesis
4.2. By Ion Semiconductor Sequencing
4.3. By Nanopore Sequencing
4.4. By Single-Molecule Real-Time Sequencing
4.5. By Other Technologies
5. Global Next-Generation Sequencing Market - by Application
5.1. By Diagnostics
5.2. By Cancer Diagnostics
5.3. By Infectious Disease Diagnostics
5.4. By Reproductive Health Diagnostics
5.5. By Other Diagnostic Applications
5.6. By Drug Discovery
5.7. By Agricultural & Animal Research
5.8. By Other Applications
6. Global Next-Generation Sequencing Market - by End User
6.1. By Academic Institutes & Research Centers
6.2. By Pharmaceutical & Biotechnology Companies
6.3. By Hospitals & Clinics
6.4. By Other End Users
7. Global Next-Generation Sequencing Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Next-Generation Sequencing Market - Segment Analysis
1. Overview
2. North America Next-Generation Sequencing Market, 2021 - 2034 (USD Million)
3. North America Next-Generation Sequencing Market - by Products & Services
3.1. By NGS Consumables
3.2. By Sequencing Services
3.3. By Exome & Targeted Resequencing & Custom Panels
3.4. By Whole-Genome Sequencing & De Novo Sequencing
3.5. By RNA Sequencing
3.6. By Other Sequencing Services
3.7. By Presequencing Products & Services
3.8. By Library Preparation & Target Enrichment
3.9. By Quality Control
3.10. By NGS Platforms
3.11. By Illumina
3.12. By Thermo Fisher Scientific
3.13. By Oxford Nanopore Technologies
3.14. By Pacific Biosciences
3.15. By Other Platforms
3.16. By Bioinformatics
3.17. By Services For NGS Platforms
4. North America Next-Generation Sequencing Market - by Technology
4.1. By Sequencing By Synthesis
4.2. By Ion Semiconductor Sequencing
4.3. By Nanopore Sequencing
4.4. By Single-Molecule Real-Time Sequencing
4.5. By Other Technologies
5. North America Next-Generation Sequencing Market - by Application
5.1. By Diagnostics
5.2. By Cancer Diagnostics
5.3. By Infectious Disease Diagnostics
5.4. By Reproductive Health Diagnostics
5.5. By Other Diagnostic Applications
5.6. By Drug Discovery
5.7. By Agricultural & Animal Research
5.8. By Other Applications
6. North America Next-Generation Sequencing Market - by End User
6.1. By Academic Institutes & Research Centers
6.2. By Pharmaceutical & Biotechnology Companies
6.3. By Hospitals & Clinics
6.4. By Other End Users
Chapter 5 Europe Next-Generation Sequencing Market - Segment Analysis
1. Overview
2. Europe Next-Generation Sequencing Market, 2021 - 2034 (USD Million)
3. Europe Next-Generation Sequencing Market - by Products & Services
3.1. By NGS Consumables
3.2. By Sequencing Services
3.3. By Exome & Targeted Resequencing & Custom Panels
3.4. By Whole-Genome Sequencing & De Novo Sequencing
3.5. By RNA Sequencing
3.6. By Other Sequencing Services
3.7. By Presequencing Products & Services
3.8. By Library Preparation & Target Enrichment
3.9. By Quality Control
3.10. By NGS Platforms
3.11. By Illumina
3.12. By Thermo Fisher Scientific
3.13. By Oxford Nanopore Technologies
3.14. By Pacific Biosciences
3.15. By Other Platforms
3.16. By Bioinformatics
3.17. By Services For NGS Platforms
4. Europe Next-Generation Sequencing Market - by Technology
4.1. By Sequencing By Synthesis
4.2. By Ion Semiconductor Sequencing
4.3. By Nanopore Sequencing
4.4. By Single-Molecule Real-Time Sequencing
4.5. By Other Technologies
5. Europe Next-Generation Sequencing Market - by Application
5.1. By Diagnostics
5.2. By Cancer Diagnostics
5.3. By Infectious Disease Diagnostics
5.4. By Reproductive Health Diagnostics
5.5. By Other Diagnostic Applications
5.6. By Drug Discovery
5.7. By Agricultural & Animal Research
5.8. By Other Applications
6. Europe Next-Generation Sequencing Market - by End User
6.1. By Academic Institutes & Research Centers
6.2. By Pharmaceutical & Biotechnology Companies
6.3. By Hospitals & Clinics
6.4. By Other End Users
Chapter 6 Asia Pacific Next-Generation Sequencing Market - Segment Analysis
1. Overview
2. Asia Pacific Next-Generation Sequencing Market, 2021 - 2034 (USD Million)
3. Asia Pacific Next-Generation Sequencing Market - by Products & Services
3.1. By NGS Consumables
3.2. By Sequencing Services
3.3. By Exome & Targeted Resequencing & Custom Panels
3.4. By Whole-Genome Sequencing & De Novo Sequencing
3.5. By RNA Sequencing
3.6. By Other Sequencing Services
3.7. By Presequencing Products & Services
3.8. By Library Preparation & Target Enrichment
3.9. By Quality Control
3.10. By NGS Platforms
3.11. By Illumina
3.12. By Thermo Fisher Scientific
3.13. By Oxford Nanopore Technologies
3.14. By Pacific Biosciences
3.15. By Other Platforms
3.16. By Bioinformatics
3.17. By Services For NGS Platforms
4. Asia Pacific Next-Generation Sequencing Market - by Technology
4.1. By Sequencing By Synthesis
4.2. By Ion Semiconductor Sequencing
4.3. By Nanopore Sequencing
4.4. By Single-Molecule Real-Time Sequencing
4.5. By Other Technologies
5. Asia Pacific Next-Generation Sequencing Market - by Application
5.1. By Diagnostics
5.2. By Cancer Diagnostics
5.3. By Infectious Disease Diagnostics
5.4. By Reproductive Health Diagnostics
5.5. By Other Diagnostic Applications
5.6. By Drug Discovery
5.7. By Agricultural & Animal Research
5.8. By Other Applications
6. Asia Pacific Next-Generation Sequencing Market - by End User
6.1. By Academic Institutes & Research Centers
6.2. By Pharmaceutical & Biotechnology Companies
6.3. By Hospitals & Clinics
6.4. By Other End Users
Chapter 7 Latin America Next-Generation Sequencing Market - Segment Analysis
1. Overview
2. Latin America Next-Generation Sequencing Market, 2021 - 2034 (USD Million)
3. Latin America Next-Generation Sequencing Market - by Products & Services
3.1. By NGS Consumables
3.2. By Sequencing Services
3.3. By Exome & Targeted Resequencing & Custom Panels
3.4. By Whole-Genome Sequencing & De Novo Sequencing
3.5. By RNA Sequencing
3.6. By Other Sequencing Services
3.7. By Presequencing Products & Services
3.8. By Library Preparation & Target Enrichment
3.9. By Quality Control
3.10. By NGS Platforms
3.11. By Illumina
3.12. By Thermo Fisher Scientific
3.13. By Oxford Nanopore Technologies
3.14. By Pacific Biosciences
3.15. By Other Platforms
3.16. By Bioinformatics
3.17. By Services For NGS Platforms
4. Latin America Next-Generation Sequencing Market - by Technology
4.1. By Sequencing By Synthesis
4.2. By Ion Semiconductor Sequencing
4.3. By Nanopore Sequencing
4.4. By Single-Molecule Real-Time Sequencing
4.5. By Other Technologies
5. Latin America Next-Generation Sequencing Market - by Application
5.1. By Diagnostics
5.2. By Cancer Diagnostics
5.3. By Infectious Disease Diagnostics
5.4. By Reproductive Health Diagnostics
5.5. By Other Diagnostic Applications
5.6. By Drug Discovery
5.7. By Agricultural & Animal Research
5.8. By Other Applications
6. Latin America Next-Generation Sequencing Market - by End User
6.1. By Academic Institutes & Research Centers
6.2. By Pharmaceutical & Biotechnology Companies
6.3. By Hospitals & Clinics
6.4. By Other End Users
Chapter 8 Middle East & Africa Next-Generation Sequencing Market - Segment Analysis
1. Overview
2. Middle East & Africa Next-Generation Sequencing Market, 2021 - 2034 (USD Million)
3. Middle East & Africa Next-Generation Sequencing Market - by Products & Services
3.1. By NGS Consumables
3.2. By Sequencing Services
3.3. By Exome & Targeted Resequencing & Custom Panels
3.4. By Whole-Genome Sequencing & De Novo Sequencing
3.5. By RNA Sequencing
3.6. By Other Sequencing Services
3.7. By Presequencing Products & Services
3.8. By Library Preparation & Target Enrichment
3.9. By Quality Control
3.10. By NGS Platforms
3.11. By Illumina
3.12. By Thermo Fisher Scientific
3.13. By Oxford Nanopore Technologies
3.14. By Pacific Biosciences
3.15. By Other Platforms
3.16. By Bioinformatics
3.17. By Services For NGS Platforms
4. Middle East & Africa Next-Generation Sequencing Market - by Technology
4.1. By Sequencing By Synthesis
4.2. By Ion Semiconductor Sequencing
4.3. By Nanopore Sequencing
4.4. By Single-Molecule Real-Time Sequencing
4.5. By Other Technologies
5. Middle East & Africa Next-Generation Sequencing Market - by Application
5.1. By Diagnostics
5.2. By Cancer Diagnostics
5.3. By Infectious Disease Diagnostics
5.4. By Reproductive Health Diagnostics
5.5. By Other Diagnostic Applications
5.6. By Drug Discovery
5.7. By Agricultural & Animal Research
5.8. By Other Applications
6. Middle East & Africa Next-Generation Sequencing Market - by End User
6.1. By Academic Institutes & Research Centers
6.2. By Pharmaceutical & Biotechnology Companies
6.3. By Hospitals & Clinics
6.4. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Illumina
2. Thermo Fisher Scientific
3. PerkinElmer
4. BGI Group
5. Agilent Technologies
6. Eurofins Scientific
7. Pacific Biosciences
8. Oxford Nanopore Technologies
9. QIAGEN
10. F. Hoffmann-La Roche AG
11. GENEWIZ.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By